Article
Rapsyn congenital myasthenic syndrome worsened by fluoxetine.
Muscle & nerve - 1 Jan 2017
Visser Amy C, Laughlin Ruple S, Litchy William J, Benarroch Eduardo E, Milone Margherita
Abstract excerpt
INTRODUCTION: Fluoxetine is a selective serotonin reuptake inhibitor and long-lived open channel blocker of the acetylcholine receptor, often used in the treatment of slow-channel congenital myasthenic syndromes (CMS). METHODS: We report a 42-year-old woman who had a history of episodic limb weakness that worsened after initiation of fluoxetine for treatment of depression. Genetic testing for CMS revealed a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
